MedTrace Logo

The Effects of Dexmedetomidine Dose on Motor Evoked Potentials

NCT03378973 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2020-04-28

Study results available
· View outcomes & findings →

Summary

This a parallel group, two-arm, randomized superiority trial that will compare the effect of two different doses of dexmedetomidine on motor evoked potentials during spine surgery

Conditions

  • Spinal Fusion

Interventions

DRUG

Dexmedetomidine

Patients will randomly assigned to received Arm 1 anesthesia or Arm 2 anesthesia during surgery.

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Ronald Emerson, MD · Hospital for Special Surgery, New York

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-28
Primary Completion
2019-10-17
Completion
2019-10-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03378973 on ClinicalTrials.gov